63 related articles for article (PubMed ID: 16864999)
1. Population pharmacokinetic analysis of panipenem/betamipron in patients with various degrees of renal function.
Tajima N; Ishizuka H; Naganuma H
Chemotherapy; 2006; 52(5):245-53. PubMed ID: 16864999
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease.
Ohashi N; Uematsu T; Nagashima S; Kanamaru M; Tajima N; Togawa A; Hishida A
J Infect Chemother; 2005 Feb; 11(1):24-31. PubMed ID: 15729484
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of effect of renal failure on the pharmacokinetics of panipenem in rats.
Tajima N; Soma M; Ishizuka H; Naganuma H
Biol Pharm Bull; 2005 Nov; 28(11):2170-2. PubMed ID: 16272714
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic study of memantine in healthy and renally impaired subjects.
Periclou A; Ventura D; Rao N; Abramowitz W
Clin Pharmacol Ther; 2006 Jan; 79(1):134-43. PubMed ID: 16413248
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of dexrazoxane in subjects with impaired kidney function.
Brier ME; Gaylor SK; McGovren JP; Glue P; Fang A; Aronoff GR
J Clin Pharmacol; 2011 May; 51(5):731-8. PubMed ID: 20484616
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy: a pilot study.
Hayakawa M; Ito Y; Fujita I; Iseki K; Gando S
ASAIO J; 2006; 52(4):398-403. PubMed ID: 16883119
[TBL] [Abstract][Full Text] [Related]
8. [Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin].
Hasslacher C; Vogt C; Raupp D; Dreyhaupt J
Dtsch Med Wochenschr; 2007 Nov; 132(47):2500-4. PubMed ID: 18027324
[TBL] [Abstract][Full Text] [Related]
9. Tigecycline pharmacokinetics in subjects with various degrees of renal function.
Korth-Bradley JM; Troy SM; Matschke K; Muralidharan G; Fruncillo RJ; Speth JL; Raible DG
J Clin Pharmacol; 2012 Sep; 52(9):1379-87. PubMed ID: 21953572
[TBL] [Abstract][Full Text] [Related]
10. Panipenem/betamipron.
Goa KL; Noble S
Drugs; 2003; 63(9):913-25; discussion 926. PubMed ID: 12678575
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients.
Li C; Kuti JL; Nightingale CH; Nicolau DP
J Clin Pharmacol; 2006 Oct; 46(10):1171-8. PubMed ID: 16988206
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
Kimura T; Sunakawa K; Matsuura N; Kubo H; Shimada S; Yago K
Antimicrob Agents Chemother; 2004 Apr; 48(4):1159-67. PubMed ID: 15047516
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of panipenem in neonates and retrospective evaluation of dosage.
Kimura T; Kokubun H; Nowatari M; Matsuura N; Sunakawa K; Kubo H
J Antimicrob Chemother; 2001 Jan; 47(1):51-9. PubMed ID: 11152431
[TBL] [Abstract][Full Text] [Related]
15. Dosage regimen of ranitidine in patients with renal impairment.
Ebihara A; Ohashi K; Ikeda T; Yuhara M; Tagawa H; Yamakado M; Asano Y; Tabei K; Nakazawa K; Kondo K
Int J Clin Pharmacol Res; 1989; 9(1):1-7. PubMed ID: 2707920
[TBL] [Abstract][Full Text] [Related]
16. Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency.
Pai MP; Mercier RC; Allen SE
Ann Pharmacother; 2006 Mar; 40(3):553-8. PubMed ID: 16507618
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.
Robatel C; Decosterd LA; Biollaz J; Eckert P; Schaller MD; Buclin T
J Clin Pharmacol; 2003 Dec; 43(12):1329-40. PubMed ID: 14615469
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of various gentamicin dosage regimens in geriatric patients: a simulation study.
Bourguignon L; Goutelle S; De Saint-Martin JB; Maire P; Ducher M
Fundam Clin Pharmacol; 2010 Feb; 24(1):109-13. PubMed ID: 19735306
[TBL] [Abstract][Full Text] [Related]
20. Overview of a new carbapenem, panipenem/betamipron.
Shimada J; Kawahara Y
Drugs Exp Clin Res; 1994; 20(6):241-5. PubMed ID: 7758396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
